p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Medica Hospitalia
Nur Alaydrus
Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine, Diponegoro University, Kariadi Hospital, Semarang

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

The Association Vitamin D and Left Ventricular Hypertrophy in Metabolic Syndrome Patients Charles Limantoro; Andreas Arie Setiawan; Nur Alaydrus; Theofilus Ardy Pradhana; Friska Anggraini Helena Silitonga
Medica Hospitalia : Journal of Clinical Medicine Vol. 12 No. 1 (2025): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36408/mhjcm.v12i1.1196

Abstract

Background: Vitamin D deficiency is common, especially in people with metabolic syndrome. This condition increases the risk of cardiovascular problems, including left ventricular hypertrophy (LVH). While the connection between metabolic syndrome and LVH is well-documented, it is still unclear whether vitamin D deficiency alone contributes to the development of LVH in these patients. Aim: To study the association between vitamin D levels and LVH in patients with metabolic syndrome. Methods: A cross-sectional study was conducted with 38 patients diagnosed with metabolic syndrome  in Kariadi Hospital, Semarang. Serum vitamin D levels were measured using the ELISA method, and LVH was diagnosed via echocardiography. Patients were categorized into normal and LVH groups. Vitamin D levels were classified as sufficient, insufficient, or deficient. The relationship between vitamin D levels, metabolic syndrome components, and LVH was analyzed. Results: Our findings revealed no significant difference in vitamin D levels between patients with LVH and those without it (mean 19.98 ± 5.59 ng/mL for the LVH group vs. 20.91 ± 6.56 ng/mL for the normal group, p=0.65). However, patients with LVH had a significantly higher number of metabolic syndrome components compared to those without LVH (p=0.044). Conclusion: While no direct association was found between vitamin D levels and LVH, the cumulative burden of metabolic syndrome components plays a significant role in the development of LVH. Future research should explore larger populations to investigate the therapeutic potential of vitamin D in cardiovascular outcomes.
Hypokalemia Correlates with Troponin levels in Moderate-Severe COVID-19 Patients, Independent to Coagulation Status Friska Anggraini Helena Silitonga; Nur Alaydrus; Andreas Arie Setiawan; Shila Lupiyatama; Charles Limantoro
Medica Hospitalia : Journal of Clinical Medicine Vol. 12 No. 3 (2025): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Myocardial injury is a common complication of COVID-19, often marked by elevated cardiac troponin and linked to poorer outcomes. Besides recognized causes such as viral injury, inflammation, and coagulopathy, electrolyte disturbances like hypokalemia may also increase cardiac vulnerability. SARS-CoV-2 can promote potassium loss through activation of the renin angiotensin aldosterone system, but the relationship between low potassium and troponin elevation remains unclear. Aim: To evaluate whether serum potassium levels are associated with troponin elevation in patients hospitalized with moderate to severe COVID-19, and whether this association is influenced by disease severity or D-dimer levels. Methods: Cross-sectional study of 50 adults with moderate or severe COVID-19. Serum potassium, troponin, and D-dimer were measured once during admission. Associations were tested using independent t-tests, Mann-Whitney tests, and Fisher’s exact tests, with p < 0.05 considered significant. Results: Among 50 patients (39 moderate, 11 severe COVID-19), 35 (70%) had normal potassium, 12 (24%) hypokalemia, and 3 (6%) severe hypokalemia; 9 (18%) had elevated troponin. Potassium was lower in patients with elevated troponin than in those with normal levels (3.53 ± 0.53 vs. 3.99 ± 0.58 mmol/L, p = 0.038), and potassium status was significantly associated with troponin elevation (p = 0.0401). No significant differences were detected when patients were grouped by disease severity, with potassium (p = 0.44) and troponin (p = 0.66) levels similar in moderate and severe cases. D-dimer levels were not significantly different by severity (p = 0.175) and showed no association with potassium (p = 0.24) or troponin (p = 0.91). Conclusion: In hospitalized patients with moderate to severe COVID-19, lower potassium levels were associated with elevated troponin, regardless of disease severity and without a detectable link to D-dimer status. These findings suggest hypokalemia may contribute to myocardial injury in COVID-19 and support regular monitoring and timely correction of electrolyte disturbances.